Neuroimaging and therapeutic use of psychedelics and music
Music and psychedelic drugs are potent tools to modulate affective states, and they have been used by humans throughout history. The therapeutic potentials of psychedelic drugs are being re-examined today in clinical trials, and with promising results. During psychedelic therapy, a patient typically listens to a carefully designed music playlist. In this context, music is considered to interact with the drug to facilitate therapeutic insight, often with profound emotion. This presentation will present findings from a first neuroimaging study to the acute effects of music on brain activity and connectivity after intravenous LSD in healthy volunteers, and results from a clinical trial to treat major depression with psilocybin.
Mendel Kaelen holds a master’s in neuroscience from the University of Groningen and is now a PhD candidate at Imperial College London. His research interest lies in studying the role of music in psychedelic therapy from a neuroscience perspective. For his work he uses neuroimaging data from healthy volunteers administered with LSD as well as from an ongoing clinical trial with psilocybin to treat major depression. He is research fellow of the Beckley Foundation, and board member of the OPEN Foundation